Showing 1 - 2 results of 2 for search 'M Luster', query time: 0.02s Refine Results
  1. 1
    Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit

    Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit by L. J. Wirth, C. Durante, D. J. Topliss, E. Winquist, E. Robenshtok, H. Iwasaki, M. Luster, R. Elisei, S. Leboulleux, M. Tahara

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

    The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma by S Dizdarevic, M Tulchinsky, V R McCready, J Mihailovic, S Vinjamuri, J R Buscombe, S T Lee, S Frangos, M Sathekge, Q Siraj, P Choudhury, H Bom, M Franceschi, A Ugrinska, D Paez, R Hussain, J Mailman, M Luster, I Virgolini, On behalf of the WARMTH Thyroid Group

    Published 2019-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: